
|Articles|January 6, 2017
Decrease in FDA Drug Approvals Highlight Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/decrease-in-fda-drug-approvals-highlight-specialty" target="_blank">View the story "Decrease in FDA Drug Approvals Highlight Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
2
Is Berberine Nature’s GLP-1?
3
Pharmacists Key to Counseling and Monitoring Patients Transitioning to Low-Sodium Oxybate
4
Incidence of VAIs in Patients With Chronic Kidney Disease on Dialysis Relatively Low
5














































































































































































































